Skip to main content
Lactose (India) Ltd. logo

Lactose (India) Ltd. — Investor Relations & Filings

Ticker · 524202 ISIN · INE058I01013 LEI · 335800P41RTZ4ZET8J35 BSE.NS Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-21 Report Publication Anno…
Country IN India
Listing BSE.NS 524202

About Lactose (India) Ltd.

https://www.lactoseindialimited.com/

Lactose (India) Ltd. specializes in the manufacturing and distribution of pharmaceutical excipients, with a primary focus on Lactose Monohydrate. The company produces a wide range of grades, including IP, BP, USP, and EP, catering to the diverse formulation requirements of the global pharmaceutical sector. Its product portfolio extends to dry granulated products, film coating materials, and specialty chemicals used as fillers and diluents in solid dosage forms like tablets and capsules. The company operates advanced manufacturing facilities designed to meet international quality standards and regulatory requirements. By leveraging technical expertise in carbohydrate chemistry, the firm provides essential ingredients that ensure the stability and efficacy of medicinal products. It serves a broad client base, ranging from generic drug manufacturers to large-scale enterprises, maintaining a reputation for consistency and reliability in the excipient supply chain.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 & 47(3) of SEBI (LODR) Regulations, 2015 we hereby submit the newspaper publication of financial results for quarter and year ended 31st March, 2026.
Report Publication Announcement Classification · 87% confidence The document is a BSE/SEBI LODR compliance notice under Regulation 30 & 47(3), transmitting newspaper cuttings of the advertisement of the company’s audited quarterly and annual financial results. It does not itself contain the full statutory report or detailed financial statements but merely confirms that the results advertisement has been published in newspapers and on the company website. Per the “menu vs meal” rule, this is an announcement of publication rather than the report itself. Hence it is classified as a Report Publication Announcement.
2026-05-21 English
We hereby submit the Financial Results for the Quarter and Financial Year Ended 31st March, 2026 along with the Independent Auditor''s Report
Interim / Quarterly Report Classification · 85% confidence The document is a submission under SEBI Regulation 33 containing the audited financial results for the quarter and year ended March 31, 2026, including detailed income statement line items, notes, and an independent auditor’s report. It is not a full annual report (10-K) but a standalone financial reporting of periodic results (quarterly and year) with substantive financial data. Therefore, it best matches the Interim / Quarterly Report category. FY 2026
2026-05-20 English
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of ....
Interim / Quarterly Report Classification · 83% confidence The document is an announcement to the stock exchange under SEBI (Listing Obligations & Disclosure Requirements) Regulations of the audited financial results for the quarter and year ended March 31, 2026. It includes the auditor’s report and detailed line-item financial statements (revenue, expenses, profit, etc.) rather than just high-level highlights. This is not a full annual report (10-K), nor merely an earnings release (ER) with summary metrics, nor a simple report publication notice. It constitutes a comprehensive interim/quarterly results disclosure (including Q4 and year-end figures) and thus fits the “Interim / Quarterly Report” category. FY 2026
2026-05-20 English
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....
Regulatory Filings Classification · 88% confidence The document is an exchange filing under SEBI Listing Regulation 29 notifying a Board meeting to consider and approve audited financial results, along with trading window closure/reopening. It does not itself report financials nor announce a dividend or management change; it is a routine regulatory notice. This fits the fallback category “Regulatory Filings (RNS)”.
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.